News

October 15, 2020October 15, 2020

Prenatal Smoke Exposure May Increase Baby’s Later COPD Risk, Mouse Study Says

News

Exposure to cigarette smoke during pregnancy impairs lung embryonic development, which may increase the baby’s later-in-life risk for disorders like chronic obstructive pulmonary disease (COPD), a mouse study suggests. ... Read more

October 13, 2020October 13, 2020

No Link Between Face Masks and CO2 Poisoning, Even in People With COPD, Study Finds

News

The use of face masks does not cause intoxication induced by exhaled carbon dioxide (CO2), even in people with lung function impairment such as those with chronic obstructive pulmonary ... Read more

October 8, 2020October 8, 2020

Oral Cannabinoids Linked to Higher Mortality Risk in Older COPD Patients, Study Finds

News

Older patients with chronic obstructive pulmonary disease (COPD) taking oral, synthetically-made cannabinoids — medications based on compounds found naturally in marijuana (the plant Cannabis sativa) — to manage some ... Read more

October 6, 2020October 6, 2020

ATS and 4DMedical Offering Grants for Research in COPD, Other Lung Diseases

News

The American Thoracic Society (ATS), through its Research Program and with support from 4DMedical, announced it will award three, $50,000 grants for research using a new, non-invasive technology to assess lung health. ... Read more

October 1, 2020October 1, 2020

COPD360Net Seeks to Boost Innovative Digital Health, Therapeutics

News

The COPD Foundation has launched the COPD360Net project to facilitate, assess, and accelerate clinical trials to further the development and approval of novel digital health tools and treatments for ... Read more

September 29, 2020September 29, 2020

Two Phase 3 Trials of Ensifentrine in Safely Treating COPD to Open

News

Verona Pharma has launched two Phase 3 trials to assess the safety and effectiveness of ensifentrine, its investigational inhalation treatment for chronic obstructive pulmonary disease (COPD). The trials — ... Read more

September 24, 2020September 24, 2020

COPD More Prevalent Than Estimated, With Mortality Linked to Aspergillosis, Review Finds

News

Chronic obstructive pulmonary disease (COPD) is more prevalent than previously thought and associated with a mortality rate that is likely higher than earlier estimates, a review study has found. ... Read more

September 22, 2020September 22, 2020

Agreement Reached for Hemp Facility to Support Potential COPD Therapy RespRx

News

PAO Group and Puration have entered a new agreement that will allow PAO Group to build a proprietary hemp cultivar development facility on Puration’s branded site in Farmersville, Texas, ... Read more

September 17, 2020September 17, 2020

Verona’s Ensifentrine Found to Ease Breathlessness, Improve Quality of Life

News

Nebulized ensifentrine (RPL554) — which works both to widen the airways and as an anti-inflammatory — showed a significant early effect on breathlessness in people with chronic obstructive pulmonary ... Read more

September 10, 2020September 10, 2020

SNG001 Can Safely Improve Lung Function in COPD Patients With Viral Infections, Interim Data Show

News

Synairgen‘s anti-viral therapy SNG001 has a good safety profile in people with chronic obstructive pulmonary disease (COPD), Phase 2 trial data show. The data also indicate that SNG001 induces ... Read more

Pin It on Pinterest